Cross-reactive Antibody Response to mRNA SARS-CoV-2 Vaccine After Recent COVID-19-Specific Monoclonal Antibody Therapy

Autor:	Schultz-Cherry, Stacey, McGargill, Maureen A, Thomas, Paul G, Estepp, Jeremie H, Gaur, Aditya H, Allen, E Kaitlynn, Allison, Kim J, Tang, Li, Webby, Richard J, Cherry, Sean D, Lin, Chun-Yang, Fabrizio, Thomas, Tuomanen, Elaine I, Wolf, Joshua, SJTRC Investigative Team
Rok vydání:	2021
Předmět:	and promotion of well-being SARS-CoV-2 Prevention COVID-19 Pneumonia Prevention of disease and conditions vaccine failure Vaccine Related Infectious Diseases Emerging Infectious Diseases Good Health and Well Being 3.4 Vaccines Clinical Research antibody Biodefense Pneumonia & Influenza Immunization bamlanivimab SJTRC Investigative Team Infection Lung Biotechnology Cancer
Zdroj:	Open forum infectious diseases, vol 8, iss 9
Popis:	The efficacy of coronavirus disease 2019 (COVID-19) vaccines administered after COVID-19-specific monoclonal antibody is unknown, and "antibody interference" might hinder immune responses leading to vaccine failure. In an institutional review board-approved prospective study, we found that an individual who received mRNA COVID-19 vaccination
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=od_______325::eb710fee71075d33151cece1bc5d6f0b https://escholarship.org/uc/item/93f1b0bz Zobrazit plný text záznamu